Update on status of FIRB approval and second court hearing
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Mayne Pharma Group Ltd. has announced an update regarding its acquisition by Cosette Pharmaceuticals, Inc., specifically on the status of FIRB approval and the scheduling of a second court hearing. The FIRB has extended the deadline for approval, and the court hearing is now set for a specific date and time. The announcement includes an indicative timetable for the acquisition process, which remains subject to various approvals and conditions.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26
Mayne Pharma Group Ltd. on 6ix
Story so far
Earlier from Mayne Pharma
- MYX Declaration of Unacceptable Circumstances and Orders
- Update on FIRB approval and Scheme
- MYX - Panel Conducts Proceedings and Makes Interim Orders
- Update on Scheme and Supreme Court of NSW proceedings
- MYX Scheme of Arrangement update on FIRB approval
Later from Mayne Pharma
- Pause in Trading
- Trading Halt
- Update on FIRB condition and scheme
- Mayne Pharma issues notice of intention to terminate the SID
- MYX receives purported termination notice from Cosette
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma